Cargando…

Metformin and Cancer Hallmarks: Molecular Mechanisms in Thyroid, Prostate and Head and Neck Cancer Models

Metformin is the most used drug for type 2 diabetes (T2DM). Its antitumor activity has been described by clinical studies showing reduced risk of cancer development in T2DM patients, as well as management of T2DM compared with those receiving other glucose-lowering drugs. Metformin has a plethora of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Morale, Mirian Galliote, Tamura, Rodrigo Esaki, Rubio, Ileana Gabriela Sanchez
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8945547/ https://www.ncbi.nlm.nih.gov/pubmed/35327549 http://dx.doi.org/10.3390/biom12030357

Ejemplares similares

The use of adenoviral vectors in gene therapy and vaccine approaches
por: Araújo, Natália Meneses, et al.
Publicado: (2022)

TLR4 and SARM1 modulate survival and chemoresistance in an HPV-positive cervical cancer cell line
por: Morale, Mirian Galliote, et al.
Publicado: (2022)

Molecular mechanisms and pharmacological interventions in the replication cycle of human coronaviruses
por: Simabuco, Fernando Moreira, et al.
Publicado: (2020)

Outcome and death risk of diabetes patients with Covid-19 receiving pre-hospital and in-hospital metformin therapies
por: Tamura, Rodrigo Esaki, et al.
Publicado: (2021)

Oxidative stress: therapeutic approaches for cervical cancer treatment
por: Silva, Gabriela Ávila Fernandes, et al.
Publicado: (2018)

Innate immunity and HPV: friends or foes
por: Nunes, Rafaella Almeida Lima, et al.
Publicado: (2018)

HPV-transformed cells exhibit altered HMGB1-TLR4/MyD88-SARM1 signaling axis
por: Morale, Mirian Galliote, et al.
Publicado: (2018)

Metformin and cancer hallmarks: shedding new lights on therapeutic repurposing
por: Hua, Yu, et al.
Publicado: (2023)

Is angiogenesis a hallmark of prostate cancer?
por: Taverna, Gianluigi, et al.
Publicado: (2013)

Human Prostate Cancer Hallmarks Map
por: Datta, Dipamoy, et al.
Publicado: (2016)

Genomic Hippo Pathway Alterations and Persistent YAP/TAZ Activation: New Hallmarks in Head and Neck Cancer
por: Faraji, Farhoud, et al.
Publicado: (2022)

Emerging Hallmarks of Metabolic Reprogramming in Prostate Cancer
por: Lasorsa, Francesco, et al.
Publicado: (2023)

Hallmarks of cancer and hallmarks of aging
por: Blagosklonny, Mikhail V.
Publicado: (2022)

Preventive and Therapeutic Effect of Metformin in Head and Neck Cancer: A Concise Review
por: Bouland, Cyril, et al.
Publicado: (2023)

Diagnostic Utility of Radiomics in Thyroid and Head and Neck Cancers
por: Gul, Maryam, et al.
Publicado: (2021)

Improving adenoviral vectors and strategies for prostate cancer gene therapy
por: Tamura, Rodrigo Esaki, et al.
Publicado: (2018)

Comprehensive molecular analysis of immortalization hallmarks in thyroid cancer reveals new prognostic markers
por: Montero‐Conde, Cristina, et al.
Publicado: (2022)

Metformin's Mechanisms in Attenuating Hallmarks of Aging and Age-Related Disease
por: Cheng, Fang-Fang, et al.
Publicado: (2022)

Short neck, short head, short spine, and short body height – Hallmarks of basilar invagination
por: Goel, Atul
Publicado: (2017)

Incidental thyroid carcinomas: experiences related to the surgery of head and neck cancers
por: Li, Pingdong, et al.
Publicado: (2023)

Interleukin-30: A novel microenvironmental hallmark of prostate cancer progression
por: Di Carlo, Emma
Publicado: (2014)

Endoplasmic reticulum oxidoreductase 1 alpha modulates prostate cancer hallmarks
por: Cornelius, Julian, et al.
Publicado: (2021)

Hallmarks of glycosylation in cancer
por: Munkley, Jennifer, et al.
Publicado: (2016)

Melatonin and Cancer Hallmarks
por: Talib, Wamidh H.
Publicado: (2018)

The microbiome and the hallmarks of cancer
por: Fulbright, Laura E., et al.
Publicado: (2017)

The Hallmarks of Flavonoids in Cancer
por: Ponte, Luis Gustavo Saboia, et al.
Publicado: (2021)

Heparanase and the hallmarks of cancer
por: Jayatilleke, Krishnath M., et al.
Publicado: (2020)

An Update to Hallmarks of Cancer
por: Ravi, Swapna, et al.
Publicado: (2022)

Cancer Hallmarks, Biomarkers and Breast Cancer Molecular Subtypes
por: Dai, Xiaofeng, et al.
Publicado: (2016)

Impact of metformin on disease control and survival in patients with head and neck cancer: a retrospective cohort study
por: Lee, Daniel J., et al.
Publicado: (2019)

Lack of chemopreventive efficacy of metformin in rodent models of urinary bladder, head and neck, and colon/intestine cancer
por: Thompson, Matthew D., et al.
Publicado: (2017)

Survival Benefit of Metformin as an Adjuvant Treatment for Head and Neck Cancer: A Systematic Review and Meta-Analysis
por: Jiao, Yu, et al.
Publicado: (2022)

Prognostic value of diabetes and metformin use in a real-life population of head and neck cancer patients
por: De Falco, Vincenzo, et al.
Publicado: (2023)

Postoperative IMRT in head and neck cancer
por: Studer, Gabriela, et al.
Publicado: (2006)

The Molecular Hallmarks of the Serrated Pathway in Colorectal Cancer
por: De Palma, Fatima Domenica Elisa, et al.
Publicado: (2019)

An Epithelial–Mesenchymal Transition Hallmark Gene-Based Risk Score System in Head and Neck Squamous-Cell Carcinoma
por: Liang, Feifei, et al.
Publicado: (2021)

One patient - three head and neck primaries: nasopharyngeal, tongue and thyroid cancers
por: Fareed, Muhammad Mohsin, et al.
Publicado: (2013)

HPV-Mediated Resistance to TNF and TRAIL Is Characterized by Global Alterations in Apoptosis Regulatory Factors, Dysregulation of Death Receptors, and Induction of ROS/RNS
por: Cabeça, Tatiane Karen, et al.
Publicado: (2019)

Head and Neck Cancer
por: Psyrri, Amanda, et al.
Publicado: (2009)

Head and neck cancer
por: Kowalski, Luiz Paulo
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_34gnughf1r2brol9andguf6flf